BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Do-Thi VA, Lee JO, Lee H, Kim YS. Crosstalk between the Producers and Immune Targets of IL-9. Immune Netw 2020;20:e45. [PMID: 33425430 DOI: 10.4110/in.2020.20.e45] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Kotyla PJ, Engelmann M, Giemza-Stokłosa J, Wnuk B, Islam MA. Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role? Int J Mol Sci 2021;22:2449. [PMID: 33671049 DOI: 10.3390/ijms22052449] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
2 Lee J, Park Y, Jang SG, Hong SM, Song YS, Kim MJ, Baek S, Park SH, Kwok SK. Baricitinib Attenuates Autoimmune Phenotype and Podocyte Injury in a Murine Model of Systemic Lupus Erythematosus. Front Immunol 2021;12:704526. [PMID: 34497607 DOI: 10.3389/fimmu.2021.704526] [Reference Citation Analysis]
3 He S, Chen L, Hao X, Yang Y, Shang S. First Characterization of Chicken Interleukin-9. Front Immunol 2022;13:889991. [DOI: 10.3389/fimmu.2022.889991] [Reference Citation Analysis]
4 Omata Y, Frech M, Saito T, Schett G, Zaiss MM, Tanaka S. Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity. Int J Mol Sci 2022;23:1104. [PMID: 35163028 DOI: 10.3390/ijms23031104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Patrussi L, Capitani N, Baldari CT. Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia. Cancers (Basel) 2021;13:6301. [PMID: 34944921 DOI: 10.3390/cancers13246301] [Reference Citation Analysis]